Education
About Us
Working with TipRanks
Follow Us
Intervacc AB (DE:2E9)
:2E9
Comparison Results
IRLAB Therapeutics AB Class A
kr1.98
€204.70M
-1.53
-82.01%
0 Buy
0 Hold
0 Sell
Moderate Sell
Performance Comparison
DE:2E9
Intervacc AB
0.03
-0.12
-78.21%
SE:XBRANE
Xbrane Biopharma AB
10.98
-10.52
-48.91%
SE:ELIC
Elicera Therapeutics AB
5.94
4.17
234.65%
SE:ACE
Ascelia Pharma AB
3.07
-0.39
-11.14%
SE:IRLAB.A
IRLAB Therapeutics AB Class A
1.97
-8.98
-82.01%
SE:IMMU
Immunicum AB
5.09
-3.61
-41.48%